[11C]DAA1106: Radiosynthesis and in vivo binding to peripheral benzodiazepine receptors in mouse brain

Nuclear Medicine and Biology

Volumn 30, Issue 5, 2003, Pages 513-519

  Zhang, Ming Rong ^a   Kida, Takayo ^a,b   Noguchi, Junko ^a,b   Furutsuka, Kenji ^a,b   Maeda, Jun ^a,b   Suhara, Tetsuya ^a,c   Suzuki, Kazutoshi ^a  

^a NATIONAL INSTITUTE OF RADIOLOGICAL SCIENCES   (Japan)

^b 141 0032   (Japan)

^c JAPAN SCIENCE AND TECHNOLOGY AGENCY   (Japan)

Author keywords

Carbon 11; DAA1106; PBR; Peripheral benzodiazepine receptor; PET

Indexed keywords

ACETAMIDE DERIVATIVE; BENZODIAZEPINE RECEPTOR; CARBON 11; N (2,5 DIMETHOXYBENZYL) N (5 FLUORO 2 PHENOXYPHENYL)ACETAMIDE; RADIOLIGAND; SODIUM HYDROXIDE; TRACER; UNCLASSIFIED DRUG;

ANIMAL TISSUE; ARTICLE; BRAIN; BRAIN LEVEL; BRAIN REGION; CEREBELLUM; DRUG BINDING; DRUG METABOLISM; DRUG POTENCY; DRUG SYNTHESIS; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; ISOTOPE LABELING; MALE; METHYLATION; MITOCHONDRION; MONKEY; MOUSE; NONHUMAN; OLFACTORY BULB; POSITRON; PURIFICATION; RADIOACTIVITY; RADIOCHEMISTRY; RADIOISOTOPE DECAY; RECEPTOR BINDING;

EID: 0037756795     PISSN: 09698051     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0969-8051(03)00016-7     Document Type: Article

References (33)

1. Andrews J.W., Stephents D.N. File S.E. Psychopharmacology of anxiolytics and antidepressants. 1991;103-130 Pergamon Press, New York.
2. Anholt R.R.H., DeSouza E.B., Oster-Granite M.L., Synder S.H. Peripheral-type benzodiazepine receptors autoradiographic localization in whole-body sections of neonatal rats . J. Pharmac. Exp. Ther. 233:1985;517-526.
3. Banati R., Newcombe J., Gunn R., Cagnin A., Turkheimer F., Heppner F., Price G., Wegner F., Giovannonni G., Miller D., Perkin G., Smith T., Hewson A., Bydder G., Kreutzber G., Jones T., Cuzner M., Myers R. The peripheral-type benzodiazepine binding sites in the brain in multiple sclerosis: Quantitative in vivo imaging of microglia as a measure of disease activity. Brain. 123:2000;2321-2337.
4. 3H]PK11195, an isoquinoline carboxamide derivatives; kinetic studies and autoradiographic localization. J. Neurochem. 41:1983;1744-1750.
5. Berson A., Descatoire V., Sutton A., Fau D., Maulny B., Vadrot N., Feldmann G., Berthon B., Tordjmann T., Pessayre D. Toxicity of alpidem, a peripheral benzodiazepine receptor ligand, but not zolpidem, in rat hepatocytes role of mitochondrial permeability transition and metabolic activation . J. Pharmacol. Exp. Ther. 299:2001;793-800.
6. 3H]dizaepam binding. Proc. Natl. Acad. Sci. U.S.A. 74:1977;1839-1847.
7. 11C]-methyl, N-(methyl-1-propyl), (chloro-2-phenyl)-1-isoquinoline carboxamide-3 (PK11195) a new ligand for peripheral benzodiazepine receptors . J. Labelled Comp. Radiopharm. 21:1984;985-991.
8. 3H]DAA1106, a novel and selective ligand for peripheral benzodiazepine receptor. Eur. J. Pharmacolo. 371:1999;197-204.
9. Farde L. The advantage of using positron emission tomography in drug research. Trends Neurosci. 19:1996;211-214.
10. Diorio D., Welner S., Butterworth R., Meaney M., Suranyl-Cadotte B. Peripheral benzodiazepine binding sites in Alzheimer's disease frontal cortex and temporal cortex. Neurobiol. Aging. 12:1991;255-258.
11. Farde L. The advantage of using positron emission tomography in drug research. Trends Neurosci. 19:1996;211-214.
12. Ferzaz B., Brault E., Bourliaud G., Robert J.P., Poughon G., Claustre Y., Marguet F., Liere P., Schumacher M., Fournier J., Marabout B., Sevrin M., George P., Benavides J., Scatton B. SR180575 (7-Chloro-N, N,5-trimethyl-4-oxo-3-phenyl-3,5-dihydro-4H-pyridazino[4,5-b]indole-1- acetamide), a peripheral benzodiazepine receptor ligand, promotes neuronal survival and repair. J. Pharmacol. Exp. Ther. 301:2002;1067-1078.
13. Fowler J.S., Volkow N.D., Wang G.-J., Ding Y.-S., Dewey S.L. PET and drug research and development. J. Nucl. Med. 40:1999;1154-1163.
14. 3H]PK11195. Res. Commun. Mol. Pathol. Pharmacol. 105:1999;35-41.
15. Gavisg M., Katz Y., Bar-Ami S., Wizman R. Biochemical, physiological and pathological aspects of the peripheral benzodiazepine receptor. J. Neurochem. 58:1992;1589-1602.
16. 11C-PK11195 for in vivo study of peripheral-type benzodiazepine receptors using positron emission tomography. Ann. Nucl. Med. 3:1989;63-71.
17. Messmer K., Reynolds G. Increased peripheral benzodiazepine binding sites in the brain of patients with Huntington's disease. Neurosci. Lett. 241:1998;91-98.
18. Okuyama S., Chaki S., Yoshikawa R., Ogawa S., Suzuki Y., Okubo T., Nakazato A., Nagamine M., Tomisawa K. Neuropharmacol.ogical profile of peripheral benzodiazepine receptor agonists, DAA1097 and DAA1106. Life Sci. 64:1999;1455-1464.
19. Papadopoulos V., Amri H., Li H., Yao Z., Brown R.C., Vidic B., Culty M. Structure, function and regulation of the mitochondrial peripheral-type benzodiazepine receptor. J. Pharmacol. Exp. Ther. 299:2001;793-800.
20. Pappata S., Cornu P., Samson Y., Benavides J., Scatton B., Crouzel C., Hauw J.J. A. Syrota A, PET study of carbon-11-PK11195 binding to peripheral type benzodiazepine sites in glioblastoma a case report . J. Nucl. Med. 32:1991;1608-1610.
21. 11C]PK11195. Neurology. 55:2000;1052-1054.
22. Remeo E., Auta J., Kozikowski A., Ma D., Papadopoulos V., Puia G., Guidotti A. 2-Aryl-3-indoleacetamides (FGIN-1) a new class of potent and specific ligand for the mitochondrial DBI receptor (MDR) . J. Pharmacol. Exp. Ther. 262:1992;971-978.
23. 18F]PK14105 as markers for neuronal damage . J. Neurochem. 55:1990;175-185.
24. Sauvageau A., Desjardins P., Lozeva V., Rose C., Hazell A.S., Bouthillier A., Butterwort R.F. Increased expression of "peripheral-type" benzodiazepine receptors in human temporal lobe epilepsy implications for PET imaging of hippocampal sclerosis . Metab. Brain. Dis. 17:2002;3-11.
25. 3H]Ro5-4864 benzodiazepine binding sites in rat cerebral cortex. Eur. J. Pharmacol. 71:1981;173-175.
26. Selleri S., Bruni F., Costagli C., Costanzo A., Guerrini G., Ciciani G., Costa B., Martini C. 2-Arylpyrazolo[1,5-a]pyrimidin-3-yl acetamides, New potent and selective peripheral benzodiazepine receptor ligands. Bioorg. Med. Chem. 9:2001;2661-2671.
27. Stephenson D., Scober D., Smaltig E., Mincy E., Gehlert D., Clements J. Peripheral benzodiazepine receptors are colocalized with activated microglia following transient global forbrain ischemia in the rat. J. Nuerosci. 15:1995;5263-5274.
28. 11C]Ro15-1788. Appl. Radiat. Isot. 36:1985;971-976.
29. Takei M., Kida T., Suzuki K. Sensitive measurement of positron emitters eluted from HPLC. Appl. Radiat. Isot. 55:2001;229-234.
30. Tallman J.F., Thomas J.W., Gallager D.W. GABAergic modulation of benzodiazepine binding site sensitivity. Nature. 274:1978;383-385.
31. Tallman J.F., Paul S.M., Skolick P., Gallager D.W. Receptors for the age of anxiety pharmacology of the benzodiazepine . Science. 207:1980;274-281.
32. 18F]FEtP4A, a promising PET tracer for mapping acetylcholinesterase in vivo . Nucl. Med. Biol. 29:2002;463-468.
33. Zisterer D.M., Williams D.C. Peripheral-type benzodiazepine receptors. Gen. Pharmac. 29:1997;305-314.